C3 and age-related macular degeneration: Accordingly, findings from preclinical models suggest inhibition of C3 as a therapeutic strategy in AMD may be detrimental in the long term [15], and that the genetic ablation of C3 in mice decreases apoptotic cell clearance and accelerates photoreceptor degeneration [16].